Ignite Creation Date:
2025-12-24 @ 5:07 PM
Ignite Modification Date:
2026-03-14 @ 5:52 AM
Study NCT ID:
NCT02906150
Status:
UNKNOWN
Last Update Posted:
2016-09-19
First Post:
2016-09-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Thymosin Alpha 1 Plus Maintenance Therapy With the Standard of Care (SoC) in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC), EGFR Wild Type
Sponsor:
SciClone Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SCI-Ta1-NSCLC-CHEMO P2-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None